Conference Reports for NATAP
The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
Back
36 Months of Treatment With Seladelpar Is Associated With Stable or Improved Liver Stiffness in Patients With Primary Biliary Cholangitis
AASLD 2025 Nov 7-11 Wash DC
Christopher L. Bowlus1
